Feed aggregator

Scott Gottlieb's FDA Revamps Regulations on Medical Software

ACSH - 7 hours 8 min ago

As part of regulatory reform and in the face of increasing use of computer algorithms in patient care, the FDA has released draft guidelines for software that aids physicians and patients.

   
Categories: ACSH

Gene Therapy Effectively Treats Hemophilia B

ACSH - 8 hours 35 min ago

Scientists report they have successfully treated hemophilia B by giving sufferers gene therapy. When they infuse a gene for the correct blood clotting factor, it is taken up by the patient who then can produce it on their own. This means they no longer have to inject clotting factor to avoid the sometimes crippling or fatal effects of their disease.

         
Categories: ACSH

General Anesthesia Works on Plants Too

ACSH - 15 hours 34 min ago

Today, surgery and anesthesia go hand in hand. For many medical procedures, being both unresponsive and unconscious is a luxury that did not always exist. Anesthesia was used for the first time during a surgical procedure in 1846 to remove a tumor from the neck of a patient.

Categories: ACSH

Marine turtles dying after becoming entangled in plastic rubbish

Eurekalert - 23 hours 34 min ago
Hundreds of marine turtles die every year after becoming entangled in rubbish in the oceans and on beaches, including plastic 'six pack' holders and disgarded fishing gear.
Categories: Content

Teenagers with incontinence are at risk of underachieving at secondary school

Eurekalert - 23 hours 34 min ago
New research has found teenagers with incontinence are at greater risk of underachieving academically, and need more support to remove barriers so they can reach their academic potential.
Categories: Content

Omalizumab improves efficacy of oral immunotherapy for multiple food allergies

Eurekalert - 23 hours 34 min ago
Combining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves the efficacy of OIT for children with allergies to multiple foods, new clinical trial findings show. After 36 weeks, more than 80 percent of children who received omalizumab and OIT could safely consume two-gram portions of at least two foods to which they were allergic, compared with only a third of children who received placebo and OIT.
Categories: Content

Dark side of the moon: Motorcycle deaths linked to full moons

Eurekalert - 23 hours 34 min ago
On nights illuminated by a full moon, fatal motorcycle accidents increased by 5 percent compared to nights without a full moon. On evenings when the supermoon decorated the sky, this increased to 32 percent.
Categories: Content

Study identifies barriers to transplant therapy to treat multiple myeloma among racial minority groups

Eurekalert - 23 hours 34 min ago
A study by researchers at Mayo Clinic's campus in Jacksonville, Fla., has found that barriers to patients receiving stem cell therapy as part of their treatment for multiple myeloma include income, education, insurance status and access to care at an academic center or facility that treats a high volume of patients.
Categories: Content

Transfusion dependence a barrier to quality end-of-life care for some with leukemia

Eurekalert - 23 hours 34 min ago
For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions, according to a new study being presented during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta. The study associates this reduced access and consequent diminished use of hospice services with a reduced quality of end-of-life care for these patients.
Categories: Content

Two holograms in one surface

Eurekalert - 23 hours 34 min ago
Engineers at Caltech have developed a way to encode more than one hologram in a single surface with no loss of resolution.
Categories: Content

People aged 75 years and older are underrepresented in blood cancer clinical trials

Eurekalert - 23 hours 34 min ago
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the US FDA found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th ASH Annual Meeting and Exposition in Atlanta.
Categories: Content

New silicon structure opens the gate to quantum computers

Eurekalert - 23 hours 34 min ago
In a major step toward making a quantum computer using everyday materials, a team led by researchers at Princeton University has constructed a key piece of silicon hardware capable of controlling quantum behavior between two electrons with extremely high precision.
Categories: Content

Single-dose vaccine could provide faster protection in cholera epidemics

Eurekalert - 23 hours 34 min ago
Each year there are more than three million cases of cholera worldwide. Research at the University of Maryland School of Medicine now shows that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks more quickly.
Categories: Content

Survivorship care plan improves cancer care-related distress levels for HCT recipients

Eurekalert - 23 hours 34 min ago
Survivorship care plan improves patient cancer care-related distress levels for hematopoietic cell transplant recipients. Results from a recent multicenter study presented at the American Society of Hematology (ASH) Annual Meeting.
Categories: Content

CAR T-cell therapies drive outcomes in lymphoma, myeloma

Eurekalert - 23 hours 34 min ago
For people with certain types of aggressive, refractory blood cancers, treatment options are woefully limited. But three studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta spotlight the emerging role played by chimeric antigen receptor (CAR) T-cell therapies in helping individuals mount a clinical response and, in some cases, achieve durable remission.
Categories: Content

Drug suppresses spread of breast cancer caused by stem-like cells

Eurekalert - 23 hours 34 min ago
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, report University of California San Diego School of Medicine and Moores Cancer Center researchers.
Categories: Content

Quality control is vital for the energy production of cells

Eurekalert - 23 hours 34 min ago
Researchers have uncovered a mitochondrial error-correction mechanism, which is vital for the construction of the mitochondrial respiratory chain and the energy production of cells.
Categories: Content

Your mood depends on the food you eat, and what you should eat changes as you get older

Eurekalert - 23 hours 34 min ago
Diet and dietary practices differentially affect mental health in young adults versus older adults, according to new research from Binghamton University, State University of New York.
Categories: Content

Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy

Eurekalert - 23 hours 34 min ago
A new study shows that attaching antibody-like RNA nanoparticles to microvesicles can deliver effective RNA therapeutics specifically to cancer cells. Researchers used RNA nanotechnology to apply the RNA nanoparticles and control their orientation. The microscopic, therapy-loaded extracellular vesicles successfully targeted three types of cancer in animal models. The findings could lead to a new generation of anticancer drugs that use siRNA, microRNA and other RNA-interference technologies.
Categories: Content

How do you track a secretive hawk? Follow the isotopes

Eurekalert - 23 hours 34 min ago
A study by the University of Cincinnati found that the rare Henst's goshawk of Madagascar hunts lemurs in low-lying areas that are most at risk to deforestation. Researchers could use this isotope analysis to study the habitat and prey needs of other threatened species that are difficult to track.
Categories: Content